Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | January 23, 2014

Federal Circuit Decision on Patent Term Adjustment

Blog | January 17, 2014

EDTX admits plaintiff's EMVR testimony

Blog | January 15, 2014

180-Day Statute of Limitations Under 35 U.S.C. 154(b)(3) & (4) Applies to Final Patent Term Adjustment Determinations, Although Time Between Allowance and Issuance Should Not Be Excluded

Blog | January 15, 2014

EDTX allows cost savings approach for royalties, based on cost of entire location network

Blog | January 13, 2014

SDNY grants SJ of no pre-notice damages where plaintiff failed to plead marking

Blog | December 24, 2013

SDNY comments on EMVR's application in pharma context

Blog | December 23, 2013

DUtah Uses Infringer's Profits to Compute Royalty; Comments on Obligation to Award Reasonable Royalty

Article | December 20, 2013

Timing of PTO Disclosures - A Trap for the Unwary

Blog | December 18, 2013

SDNY orders ongoing royalty as percentage of wholesale price

Article | December 18, 2013

Validity Challenges: District Court v. Patent Office

Blog | November 25, 2013

NDCA precludes lost profits where damage was to plaintiff's related entity, not plaintiff itself

Blog | November 22, 2013

Update on pleading standards in Hatch-Waxman cases